Global Oncology Information Systems (OIS) Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

Oncology Information Systems (OIS) Market Size

• The global oncology information systems (OIS) market size was valued at USD 3.17 billion in 2025and is expected to reach USD 6.04 billion by 2033, at a CAGR of 8.4% during the forecast period
• Market growth is primarily driven by the rising global cancer burden, increasing adoption of digital health solutions in oncology workflows, and the need for integrated platforms that streamline radiation, medical, and surgical oncology data management
• In addition, the growing shift toward value-based care, expanding use of AI-driven treatment planning tools, and increasing integration of electronic health records (EHR) with oncology systems are accelerating market expansion globally

Oncology Information Systems (OIS) Market Analysis

• Oncology Information Systems (OIS) enable end-to-end management of cancer care workflows, including patient records, treatment planning, radiation therapy management, and clinical decision support across oncology departments
• The increasing complexity of cancer treatment protocols, coupled with the need for precision medicine and multidisciplinary care coordination, is driving adoption of integrated OIS platforms across hospitals and cancer centers
• North America dominated the oncology information systems (OIS) market with the largest revenue share of 42.6% in 2025, supported by advanced healthcare IT infrastructure, high cancer prevalence, and early adoption of digital oncology solutions across major healthcare networks
• Asia-Pacific is expected to be the fastest-growing region in the oncology information systems (OIS) market during the forecast period, driven by rising cancer incidence, expanding healthcare digitization, and increasing investments in hospital IT infrastructure
• Software / solutions dominated the oncology information systems (OIS) market in 2025 due to high demand for integrated oncology workflows, while services are gaining traction with increasing need for system customization, training, and ongoing technical support

Report Scope and Oncology Information Systems (OIS) Market Segmentation

Oncology Information Systems (OIS) Market Trends

“AI-Driven Integration and Cloud-Based Oncology Workflows”

• A key trend shaping the OIS market is the rapid adoption of AI-enabled oncology platforms that assist clinicians in treatment planning, dose optimization, and predictive patient outcomes
• For instance, solutions from Varian Medical Systems and Elekta AB increasingly incorporate AI-assisted radiation therapy planning and adaptive treatment workflows
• Cloud-based oncology platforms are enabling seamless data sharing across hospitals, cancer centers, and research institutions, improving care coordination and reducing treatment delays
• Integration of OIS with EHR systems, imaging platforms, and laboratory systems is enhancing clinical decision-making and improving multidisciplinary collaboration
• The shift toward personalized cancer treatment is increasing demand for advanced analytics and real-time patient monitoring capabilities within OIS platforms

Oncology Information Systems (OIS) Market Dynamics

Driver

“Rising Cancer Burden and Demand for Integrated Care Platforms”

• The increasing global incidence of cancer is the primary driver of OIS adoption across healthcare institutions
• Healthcare providers are increasingly relying on integrated oncology platforms to manage complex treatment workflows across multiple specialties
• Growing emphasis on precision medicine and multidisciplinary cancer care is accelerating deployment of advanced OIS solutions
• Expanding digital transformation initiatives in hospitals are further supporting adoption of oncology-specific IT systems
• Government investments in cancer care infrastructure are boosting demand for standardized oncology data management systems

Restraint/Challenge

“High Implementation Costs and Data Integration Complexity”

• High initial investment and ongoing maintenance costs of oncology information systems remain a key barrier, particularly in developing regions
• Integration challenges with legacy hospital systems and fragmented data sources can slow down adoption
• Data privacy concerns and strict regulatory compliance requirements add complexity to system deployment
• Lack of skilled IT professionals in oncology-specific informatics can limit effective system utilization
• Resistance to workflow changes among clinical staff may delay full-scale implementation

Oncology Information Systems (OIS) Market Scope

The market is segmented based on product & services, application, and end user.

• By Product & Services

On the basis of product & services, the global Oncology Information Systems (OIS) market is segmented into Software / Solutions and Professional / Support Services. The Software / Solutions segment dominated the market in 2025, driven by the growing demand for integrated oncology platforms that enable seamless management of patient data, treatment planning, radiation therapy workflows, and clinical decision support. These solutions are widely adopted across hospitals and cancer centers due to their ability to improve treatment accuracy, enhance multidisciplinary coordination, and support precision oncology. Increasing integration with electronic health records (EHR), imaging systems, and laboratory platforms further strengthens segment dominance. In addition, the rising adoption of AI-enabled oncology software, cloud-based deployment models, and advanced analytics capabilities is accelerating efficiency and reinforcing the leadership of this segment in global cancer care management.

The Professional / Support Services segment is expected to witness the fastest growth during the forecast period, driven by increasing demand for implementation, customization, training, system integration, and ongoing technical support. As healthcare organizations adopt increasingly complex oncology IT ecosystems, the need for specialized services to ensure smooth deployment, interoperability, and system optimization is rising significantly. Growing reliance on cloud-based oncology platforms and AI-powered tools is also increasing demand for continuous upgrades, data migration support, and cybersecurity management. Furthermore, expanding digital transformation initiatives across hospitals and cancer centers, especially in emerging markets, are contributing to rapid growth in this segment.

• By Application

On the basis of application, the global Oncology Information Systems (OIS) market is segmented into Medical Oncology, Radiation Oncology, and Surgical Oncology. The Radiation Oncology segment dominated the market in 2025, driven by the extensive use of OIS platforms in radiation therapy planning, dose optimization, treatment simulation, and patient monitoring. Radiation oncology heavily depends on advanced software systems for precision treatment delivery and workflow coordination, making OIS an essential component in radiotherapy departments. Strong adoption of AI-based treatment planning tools, image-guided radiation therapy (IGRT), and adaptive radiotherapy solutions further strengthens segment leadership. Increasing cancer incidence and rising demand for technologically advanced radiation treatments are also supporting continued dominance of this segment globally.

The Medical Oncology segment is expected to witness the fastest growth during the forecast period, driven by rising use of OIS platforms for chemotherapy management, drug regimen tracking, and personalized cancer treatment planning. Growing adoption of precision medicine and biomarker-based therapies is increasing the need for integrated data systems that support treatment customization and patient monitoring. The expansion of outpatient oncology services and increasing use of digital tools for long-term cancer care management are further accelerating segment growth. Additionally, integration of AI-driven clinical decision support systems in medical oncology workflows is enhancing treatment outcomes and driving adoption.

• By End User

On the basis of end user, the global Oncology Information Systems (OIS) market is segmented into Hospitals & Diagnostic Imaging Centers, Cancer / Oncology Care Centers, Government Healthcare Institutions, Research & Academic Institutes, and Specialty Clinics / Ambulatory Care Centers. The Hospitals & Diagnostic Imaging Centers segment dominated the market in 2025, driven by high patient inflow, advanced oncology departments, and strong adoption of integrated IT systems for managing complex cancer treatment workflows. Hospitals are primary centers for diagnosis, treatment planning, and multimodal cancer care, making OIS platforms essential for coordinating medical, radiation, and surgical oncology services. Increasing investments in healthcare IT infrastructure and widespread adoption of EHR-integrated oncology systems further support segment dominance.

The Cancer / Oncology Care Centers segment is expected to witness the fastest growth during the forecast period, driven by rising establishment of specialized cancer treatment facilities and increasing demand for dedicated oncology care. These centers increasingly rely on advanced OIS platforms to manage patient data, streamline treatment pathways, and support multidisciplinary care teams. Growing adoption of precision oncology, clinical trials, and personalized treatment approaches is further accelerating demand for integrated information systems. In addition, expansion of private oncology networks and rising investment in specialized cancer infrastructure across emerging economies are contributing significantly to the rapid growth of this segment.

Oncology Information Systems (OIS) Market Regional Analysis

• North America dominated the market in 2025 with a leading revenue share of 42.6%, driven by strong digital healthcare infrastructure, high cancer prevalence, and early adoption of advanced oncology IT systems.
• The region also benefits from a well-established network of specialized cancer centers and the strong presence of leading oncology software and medical technology vendors, supporting widespread implementation of integrated OIS platforms.
• In addition, favorable reimbursement frameworks for cancer care, along with high healthcare expenditure and continuous investments in hospital digitalization, are accelerating the adoption of advanced oncology information systems across the region.

U.S. Oncology Information Systems (OIS) Market Insight

The U.S. Oncology Information Systems (OIS) market is the leading national market in North America, driven by a high cancer burden, advanced healthcare IT infrastructure, and strong adoption of digital oncology solutions across hospitals and cancer centers. Widespread use of integrated OIS platforms for treatment planning, radiation therapy management, and patient data coordination is improving clinical efficiency and care outcomes. Growth is further supported by the presence of major healthcare IT vendors, high healthcare spending, and rapid adoption of AI-enabled and cloud-based oncology systems across the country.

Europe Oncology Information Systems (OIS) Market Insight

The Europe Oncology Information Systems (OIS) market is witnessing steady growth, driven by the rising burden of cancer, increasing adoption of digital healthcare solutions, and strong emphasis on standardized and guideline-based oncology care across the region. Healthcare systems in countries such as Germany, the U.K., and France are increasingly integrating OIS platforms to improve treatment planning, enhance multidisciplinary collaboration, and streamline patient data management across hospitals and cancer centers. Growth is further supported by favorable government initiatives for cancer control, expanding hospital IT infrastructure, and rising adoption of advanced technologies such as AI-enabled clinical decision support and cloud-based oncology systems, which are improving efficiency and care coordination across Europe.

U.K. Oncology Information Systems (OIS) Market Insight

The U.K. Oncology Information Systems (OIS) market is growing steadily, supported by a rising cancer burden, strong national cancer care programs, and increasing adoption of digital health technologies across the National Health Service (NHS). Healthcare providers are increasingly implementing OIS platforms to enhance treatment planning, improve multidisciplinary coordination, and streamline patient data management in oncology care. Growth is further driven by expanding use of integrated electronic health records, rising focus on personalized cancer treatment, and increasing adoption of cloud-based and AI-enabled oncology solutions to improve clinical efficiency and patient outcomes across hospitals and cancer centers.

Germany Oncology Information Systems (OIS) Market Insight

The Germany Oncology Information Systems (OIS) market is expanding steadily, supported by a strong healthcare infrastructure, high cancer prevalence, and increasing focus on advanced digitalization within hospital systems. German healthcare providers are widely adopting OIS platforms to improve precision in treatment planning, enhance workflow efficiency in radiation and medical oncology, and ensure seamless integration of patient data across departments. Growth is further driven by the country’s emphasis on high-quality, standardized cancer care, strong adoption of AI-enabled clinical tools, and increasing investment in hospital IT modernization, which is accelerating the use of advanced oncology information systems across cancer treatment facilities.

Asia-Pacific Oncology Information Systems (OIS) Market Insight

The Asia-Pacific Oncology Information Systems (OIS) market is witnessing rapid growth, driven by a rising cancer burden, increasing healthcare digitization, and expanding investments in hospital IT infrastructure across emerging economies such as China, India, and Japan. Healthcare providers in the region are increasingly adopting OIS platforms to improve cancer care coordination, streamline treatment planning, and enhance patient data management across oncology departments. Growth is further supported by improving access to advanced healthcare technologies, government initiatives to strengthen cancer care services, and the growing adoption of cloud-based and AI-enabled oncology solutions, which are helping improve clinical efficiency and treatment outcomes across the region.

Japan Oncology Information Systems (OIS) Market Insight

The Japan Oncology Information Systems (OIS) market is growing steadily, supported by a rapidly aging population, high prevalence of cancer cases, and strong focus on advanced healthcare technologies. Healthcare providers in Japan are increasingly adopting OIS platforms to enhance precision in treatment planning, improve coordination across multidisciplinary oncology teams, and streamline patient data management. Growth is further driven by the country’s emphasis on high-quality, technology-driven healthcare delivery, rising adoption of AI-enabled clinical tools, and increasing use of integrated digital systems in hospitals and cancer treatment centers to improve efficiency and patient outcomes.

India Oncology Information Systems (OIS) Market Insight

The India Oncology Information Systems (OIS) market is expanding rapidly, driven by the rising incidence of cancer, increasing air pollution levels, and growing awareness of early diagnosis and cancer treatment. Healthcare providers are increasingly adopting OIS platforms to improve treatment planning, enhance patient data management, and streamline oncology workflows across hospitals and cancer care centers. Growth is further supported by improving healthcare infrastructure, rising investments in hospital digitalization, and strong expansion of private cancer care networks. In addition, increasing adoption of cloud-based and cost-effective oncology IT solutions, along with government initiatives to strengthen cancer care services, is accelerating market growth across the country.

Oncology Information Systems (OIS) Market Share

The Oncology information systems (OIS) industry is primarily led by well-established companies, including:

• Varian Medical Systems (U.S.)
• Elekta AB (Sweden)
• RaySearch Laboratories (Sweden)
• Epic Systems Corporation (U.S.)
• Cerner Corporation (U.S.)
• Merative (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• GE HealthCare (U.S.)
• Accuray Incorporated (U.S.)
• McKesson Corporation (U.S.)
• Siemens Healthineers AG (Germany)
• Agfa HealthCare (Belgium)
• MIM Software (U.S.)
• Allscripts Healthcare Solutions (U.S.)
• NextGen Healthcare (U.S.)

What are the Recent Developments in Global Oncology Information Systems (OIS) Market?

• In July 2025, Elekta strengthened its OIS ecosystem (Elekta ONE / MOSAIQ) through a partnership with Gray Oncology Solutions, integrating an AI-powered scheduling and care orchestration platform to optimize patient appointment workflows and reduce administrative delays in cancer treatment delivery.
• In September 2025, GE HealthCare introduced AI-enhanced updates to its Intelligent Radiation Therapy (iRT) workflow platform, designed to shorten radiation therapy planning timelines and improve integration with oncology information systems such as RaySearch’s RayStation, supporting faster and more precise cancer care delivery.
• In September 2025, RaySearch Laboratories expanded its OIS ecosystem through the launch of enhanced RayCare® v2025 capabilities, introducing deeper interoperability with hospital systems, AI-powered workflow automation, and improved clinical documentation features to streamline oncology care delivery across multidisciplinary cancer centers.
• In 2025, Varian (Siemens Healthineers) introduced an advanced OIS upgrade integrating AI-driven treatment planning and predictive analytics, enhancing personalization of radiation therapy and improving decision support across oncology departments.

SKU-76086